Author

W. V. van Geffen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prognostic implication of malignant pleural metastases in stage M1a non-small cell lung cancer in a real-world Dutch cohort receiving chemotherapy and/or immunotherapy.

INTRODUCTION In the updated 9th TNM non-small cell lung cancer (NSCLC) staging edition, pleural and pulmonary metastases remain grouped within the M1a category, inferring similar prognostic implications. The aim was to evaluate the prognostic implication on overall survival (OS) of pleural versus contralateral pulmonar...

A. Noordhof, R. A. M. Damhuis, Kevin G. Blyth et al. · European Respiratory Journal · 0 citations

Open access Sep 2026

Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study.

For patients with a CFI exceeding 90 days, platinum rechallenge represents a rational second-line treatment strategy and remains relevant despite the introduction of first-line chemoimmunotherapy, as a substantial proportion of patients still relapse within 180 days.

A. Eijkelboom, B. Peters, D. Dumoulin et al. · Lung Cancer · 0 citations